| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $685.1M | +28.0% |
| Cost of Revenue | $214.3M | +26.9% |
| Gross Profit | $470.7M | +28.5% |
| R&D Expense | $190.0M | +18.2% |
| SG&A Expense | $85.0M | +8.5% |
| Operating Income | -$111.6M | +7.0% |
| Interest Expense | $11.0M | -23.2% |
| Pre-tax Income | -$122.3M | +10.0% |
| Income Tax | $2.4M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $207.3M | +25.9% |
| Short-term Investments | $84.2M | +43.0% |
| Current Assets | $510.3M | +17.9% |
| Total Assets | $1.36B | +4.9% |
| Current Liabilities | $531.3M | +13.4% |
| Total Liabilities | $1.48B | +4.0% |
| Stockholders' Equity | -$120.1M | +4.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $78.2M | +45.0% |
| Capital Expenditures | $20.4M | +126.2% |
| Investing Cash Flow | -$40.0M | +87.7% |
| Financing Cash Flow | $7.4M | -97.2% |
| Free Cash Flow | $57.8M | +28.8% |
| -76.9% |
| Net Income | -$124.7M | +14.8% |
| EPS (Basic) | -$2.13 | +19.6% |
| EPS (Diluted) | -$2.13 | +19.6% |